Citations to this article

Antioxidant: a new role for RU-486 and related compounds.
S Parthasarathy, … , A J Morales, A A Murphy
S Parthasarathy, … , A J Morales, A A Murphy
Published November 1, 1994
Citation Information: J Clin Invest. 1994;94(5):1990-1995. https://doi.org/10.1172/JCI117551.
View: Text | PDF
Research Article Article has an altmetric score of 3

Antioxidant: a new role for RU-486 and related compounds.

Abstract

RU-486 (17 beta-hydroxy-4-dimethylaminophenyl-17-alpha-propenyl estrone 4,9 diene-3-one; mifepristone) is suggested to act by binding to progesterone and glucocorticoid receptors. Based on its chemical nature, we anticipated that RU-486 may have potent antioxidant properties. We used the oxidation of LDL as our model system. RU-486 and a similar compound, onapristone, at 1-5-microM concentrations, decreased the formation of oxidized LDL. LDL isolated from plasma of subjects who were orally supplemented with RU-486 was resistant to oxidation, as compared to LDL isolated from control plasma. The antioxidant effect of RU-486 appears to reside in the dimethylaminophenyl side chain moiety. Reduction of the A-ring of the steroid molecule had no effect on its antioxidant property. Analogs of RU-486 which lack the dimethylaminophenyl group, were without antioxidant activity. Levonorgestrel, which lacks the dimethylaminophenyl group failed to inhibit the oxidation of LDL even at 100-microM levels. In contrast, ethinylestradiol and estradiol which do not possess the dimethylamino group, were able to inhibit the oxidation of LDL by virtue of their phenolic steroid "A" ring. Thus RU-486, with its long half life, high plasma concentrations, association with lipoproteins, and ability to readily enter the cell may have additional intra- and extra-cellular antioxidant effects.

Authors

S Parthasarathy, A J Morales, A A Murphy

×

Total citations by year

Year: 2019 2015 2014 2012 2011 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 1 1 1 2 2 2 2 4 2 3 2 1 2 3 2 4 6 1 42
Citation information

Citations to this article (42)

Title and authors Publication Year
A new role for RU486 (mifepristone): it protects sperm from premature capacitation during cryopreservation in buffalo
J Dalal, P Kumar, RK Chandolia, S Pawaria, R Rajendran, S Sheoran, J Andonissamy, D Kumar 		Scientific Reports 2019
Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke
C Romer, O Engel, K Winek, S Hochmeister, T Zhang, G Royl, J Klehmet, U Dirnagl, C Meisel, A Meisel 		The Journal of neuroscience : the official journal of the Society for Neuroscience 2015
Antiprogestins in gynecological diseases
AA Goyeneche, CM Telleria 		Reproduction 2014
Investigation of heavy metal effects on immobilized paraoxanase by glutaraldehyde
Ç Bilen, S Beyaztaş, O Arslan, ÖÖ Güler 		Journal of Enzyme Inhibition and Medicinal Chemistry 2012
Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt, and forkhead signaling
RC Poulsen, AJ Carr, PA Hulley 		Endocrinology 2011
Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
CR Tieszen, AA Goyeneche, BA Brandhagen, CT Ortbahn, CM Telleria 		BMC Cancer 2011
Reproductive Medicine and Assisted Reproductive Techniques
FL Lopes, J Desmarais, BD Murphy 		Endometrium, The 2008
Nuclear Receptors as Drug Targets
E Ottow, H Weinmann 		2008
Progesterone receptor antagonists and selective progesterone receptor modulators: proven and potential clinical applications
IM Spitz 		Expert Review of Obstetrics & Gynecology 2007
Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo
AA Goyeneche, RW Carón, CM Telleria 		Clinical cancer research 2007
Effect of Chronic Stress and Mifepristone Treatment on Voltage-Dependent Ca2+Currents in Rat Hippocampal Dentate Gyrus
NG van Gemert, M Joëls 		Journal of Neuroendocrinology 2006
Stress Increases Vulnerability to Inflammation in the Rat Prefrontal Cortex
RM de Pablos 		The Journal of neuroscience : the official journal of the Society for Neuroscience 2006
Corticosterone Increases Damage and Cytosolic Calcium Accumulation Associated With Ethanol Withdrawal in Rat Hippocampal Slice Cultures
PJ Mulholland, RL Self, BR Harris, HJ Little, JM Littleton, MA Prendergast 		Alcoholism: Clinical & Experimental Research 2005
RU486 inhibits expression of lysophosphatidic acid induced glycodelin
S Ramachandran, MQ Song, E Lowe, CE Dominguez, S Parthasarathy, AA Murphy 		American Journal of Obstetrics and Gynecology 2005
Corticosterone and dexamethasone potentiate cytotoxicity associated with oxygen-glucose deprivation in organotypic cerebellar slice cultures
PJ Mulholland, TD Stepanyan, RL Self, AK Hensley, BR Harris, A Kowalski, JM Littleton, MA Prendergast 		Neuroscience 2005
Hormones and the Brain
C Kordon, RC Gaillard, Y Christen 		2005
A novel alkaloid antioxidant, Boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in-vitro and atherosclerosis in vivo in LDLR−/− mice
N Santanam, M Penumetcha, H Speisky, S Parthasarathy 		Atherosclerosis 2004
The steroid RU486 induces UCP1 expression in brown adipocytes
AM Rodrguez, A Palou 		Pflügers Archiv - European Journal of Physiology 2004
Progesterone antagonists and progesterone receptor modulators
IM Spitz 		Expert Opinion on Investigational Drugs 2003
Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum
AM Ghoumari, I Dusart, M El-Etr, F Tronche, C Sotelo, M Schumacher, EE Baulieu 		Proceedings of the National Academy of Sciences 2003
Progesterone antagonists and progesterone receptor modulators: an overview
IM Spitz 		Steroids 2003
Regulation and Modulation of Abnormal Immune Responses in Endometriosis
N Sidell, SW Han, S Parthasarathy 		Annals of the New York Academy of Sciences 2002
Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat
DL McCullers, PG Sullivan, SW Scheff, JP Herman 		Neuroscience 2002
Regulation of colony stimulating factor-1 (CSF-1) in endometrial cells: glucocorticoids and oxidative stress regulate the expression of CSF-1 and its receptor c-fms in endometrial cells
K Gill, N Kirma, VS Gunna, N Santanam, S Parthasarathy, RR Tekmal 		Fertility and Sterility 2001
RU486-induced growth inhibition of human endometrial cells
AA Murphy, MH Zhou, S Malkapuram, N Santanam, S Parthasarathy, N Sidell 		Fertility and Sterility 2000
Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice
M Aviram, L Dornfeld, M Rosenblat, N Volkova, M Kaplan, R Coleman, T Hayek, D Presser, B Fuhrman 		The American journal of clinical nutrition 2000
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
C Behl 		Progress in Neurobiology 1999
Stobadine: Bellwether of a broader view of drug actions
FF Vincenzi, TR Hinds 		Life Sciences 1999
The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
B Moosmann, C Behl 		Proceedings of the National Academy of Sciences 1999
Review: The Role of Cytokines in the Catabolic Consequences of Infection and Injury
HR Chang, B Bistrian 		JPEN. Journal of parenteral and enteral nutrition 1998
Neuroprotective Signal Transduction
MP Mattson 		1998
17?-Estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid ?-peptide and iron
JN Keller, A Germeyer, JG Begley, MP Mattson 		Journal of Neuroscience Research 1997
Protection Against Oxidative Stress-induced Neuronal Cell Death-A Novel Role for RU486
C Behl, T Trapp, T Skutella, F Holsboer 		European Journal of Neuroscience 1997
RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
FC PhD, AU PhD, EE PhD 		Annual Review of Medicine 1997
Clinical Pharmacology of Cerebral Ischemia
GJ Horst, J Korf 		1997
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids
G Tiao, J Fagan, V Roegner, M Lieberman, JJ Wang, JE Fischer, PO Hasselgren 		Journal of Clinical Investigation 1996
Review of progress in sterol oxidations: 1987–1995
LL Smith 		Lipids 1996
Mifepristone: Clinical Pharmacology
A Robbins, IM Spitz 		Clinical Obstetrics and Gynecology 1996
The effect of RU 486 and related compounds on cultured macrophage differentiation and function
CP Roberts, AA Murphy, N Santanam, S Parthasarathy 		American Journal of Obstetrics and Gynecology 1996
Inhibition of oxidative modification of proteins by RU486**Roussel-Uclaf, Romainville, France.††Supported by the Department of Gynecology and Obstetrics at Emory University
SE Carpenter, N Santanam, AA Murphy, JA Rock, S Parthasarathy 		Fertility and Sterility 1996
RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium**Supported by the Berlex Scholar Award, The Berlex Foundation, New York, New York (E.A.S.) and by HD-30496, National Institutes of Health, Bethesda, Maryland (to R.A.N.).††Presented at the Conjoint Meeting of The American Fertility Society and The Canadian Fertility and Andrology Society, Montreal, Quebec, Canada, October 11 to 14, 1993
EA Stewart, DJ Austin, P Jain, MD Penglase, RA Nowak 		Fertility and Sterility 1996
Effect of RU-486 and Related Compounds on the Proliferation of Cultured Macrophages
C Roberts, S Parthasarathy, R Gulati, I Horowitz, A Murphy 		American Journal of Reproductive Immunology 1995

Advertisement